Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) Invested Capital (2016 - 2025)

Historic Invested Capital for Outlook Therapeutics (OTLK) over the last 8 years, with Q4 2025 value amounting to -$38.5 million.

  • Outlook Therapeutics' Invested Capital rose 2334.63% to -$38.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$38.5 million, marking a year-over-year increase of 2334.63%. This contributed to the annual value of -$32.2 million for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q4 2025, Outlook Therapeutics' Invested Capital is -$38.5 million, which was up 2334.63% from -$32.2 million recorded in Q3 2025.
  • In the past 5 years, Outlook Therapeutics' Invested Capital ranged from a high of -$32.2 million in Q3 2025 and a low of -$50.3 million during Q4 2024